These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 8603619)
1. Comparative effects of valproate and the new experimental anticonvulsant drug alpha-ethyl-alpha-methyl-thiobutyrolactone on selected metabolite levels in the plasma, livers, and brains of infant mice. Thurston JH; Hauhart RE Epilepsia; 1996 Jan; 37(1):2-5. PubMed ID: 8603619 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the anticonvulsant activities of ethosuximide, valproate, and a new anticonvulsant, thiobutyrolactone. Ferrendelli JA; Holland KD; McKeon AC; Covey DF Epilepsia; 1989; 30(5):617-22. PubMed ID: 2507307 [TBL] [Abstract][Full Text] [Related]
3. A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: possible clinical significance. Thurston JH; Carroll JE; Hauhart RE; Schiro JA Life Sci; 1985 Apr; 36(17):1643-51. PubMed ID: 3921791 [TBL] [Abstract][Full Text] [Related]
4. Physiological comparison of alpha-ethyl-alpha-methyl-gamma-thiobutyrolactone with benzodiazepine and barbiturate modulators of GABAA receptors. Mathews GC; Bolos-Sy AM; Covey DF; Rothman SM; Ferrendelli JA Neuropharmacology; 1996 Feb; 35(2):123-36. PubMed ID: 8734480 [TBL] [Abstract][Full Text] [Related]
5. Voltage-dependent calcium channels as targets for convulsant and anticonvulsant alkyl-substituted thiobutyrolactones. Gross RA; Covey DF; Ferrendelli JA J Pharmacol Exp Ther; 1997 Feb; 280(2):686-94. PubMed ID: 9023280 [TBL] [Abstract][Full Text] [Related]
7. Relative anticonvulsant effects of GABAmimetic and GABA modulatory agents. Holland KD; McKeon AC; Canney DJ; Covey DF; Ferrendelli JA Epilepsia; 1992; 33(6):981-6. PubMed ID: 1334454 [TBL] [Abstract][Full Text] [Related]
8. Physiological regulation of the picrotoxin receptor by gamma-butyrolactones and gamma-thiobutyrolactones in cultured hippocampal neurons. Holland KD; Ferrendelli JA; Covey DF; Rothman SM J Neurosci; 1990 Jun; 10(6):1719-27. PubMed ID: 2355246 [TBL] [Abstract][Full Text] [Related]
9. Modafinil and its metabolites enhance the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Zolkowska D; Andres-Mach M; Prisinzano TE; Baumann MH; Luszczki JJ Psychopharmacology (Berl); 2015 Jul; 232(14):2463-79. PubMed ID: 25697861 [TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats. Semmes RL; Shen DD Epilepsia; 1991; 32(2):232-41. PubMed ID: 2004628 [TBL] [Abstract][Full Text] [Related]
11. Anticonvulsant activity of intracerebroventricularly administered valproate and valproate analogues. A dose-dependent correlation with changes in brain aspartate and GABA levels in DBA/2 mice. Chapman AG; Croucher MJ; Meldrum BS Biochem Pharmacol; 1984 May; 33(9):1459-63. PubMed ID: 6428419 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the pharmacological and biochemical profiles of valproic acid (VPA) and its cerebral metabolite (2-en-VPA) after oral administration in mice. Keane PE; Simiand J; Morre M Methods Find Exp Clin Pharmacol; 1985 Feb; 7(2):83-6. PubMed ID: 2859407 [TBL] [Abstract][Full Text] [Related]
13. Time course of alpha-fluorinated valproic acid in mouse brain and serum and its effect on synaptosomal gamma-aminobutyric acid levels in comparison to valproic acid. Tang W; Palaty J; Abbott FS J Pharmacol Exp Ther; 1997 Sep; 282(3):1163-72. PubMed ID: 9316822 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients]. Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630 [TBL] [Abstract][Full Text] [Related]
15. Amelioration of adverse effects of valproic acid on ketogenesis and liver coenzyme A metabolism by cotreatment with pantothenate and carnitine in developing mice: possible clinical significance. Thurston JH; Hauhart RE Pediatr Res; 1992 Apr; 31(4 Pt 1):419-23. PubMed ID: 1570210 [TBL] [Abstract][Full Text] [Related]
16. Effects of anticonvulsant lactams on in vitro seizures in the hippocampal slice preparation. Hill MW; de la Cruz MA; Covey DF; Rothman SM Epilepsy Res; 1999 Nov; 37(2):121-31. PubMed ID: 10510978 [TBL] [Abstract][Full Text] [Related]
17. 1-Methyl-1,2,3,4-tetrahydroisoquinoline enhances the anticonvulsant action of carbamazepine and valproate in the mouse maximal electroshock seizure model. Luszczki JJ; Antkiewicz-Michaluk L; Czuczwar SJ Neuropharmacology; 2006 Feb; 50(2):133-42. PubMed ID: 16153667 [TBL] [Abstract][Full Text] [Related]
18. Alkyl-substituted thiolo-, thiono-, and dithio-gamma-butyrolactones: new classes of convulsant and anticonvulsant agents. Levine JA; Ferrendelli JA; Covey DF J Med Chem; 1986 Oct; 29(10):1996-9. PubMed ID: 3761317 [TBL] [Abstract][Full Text] [Related]
19. Chronic valproate administration produces hepatic dysfunction and may delay brain maturation in infant mice. Thurston JH; Hauhart RE; Schulz DW; Naccarato EF; Dodson WE; Carroll JE Neurology; 1981 Sep; 31(9):1063-9. PubMed ID: 6791049 [TBL] [Abstract][Full Text] [Related]
20. Reversal of the adverse chronic effects of the unsaturated derivative of valproic acid--2-n-propyl-4-pentenoic acid--on ketogenesis and liver coenzyme A metabolism by a single injection of pantothenate, carnitine, and acetylcysteine in developing mice. Thurston JH; Hauhart RE Pediatr Res; 1993 Jan; 33(1):72-6. PubMed ID: 8433865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]